Long-Term Efficacy and Safety of Leflunomide in Large-Vessel Giant Cell Arteritis: A Single-Center, 10-Year Experience

J Clin Rheumatol. 2022 Jan 1;28(1):e297-e300. doi: 10.1097/RHU.0000000000001703.

Authors

Alessandro Tomelleri, Fiona Coath¹, Alwin Sebastian¹, Diana Prieto-Pena, Abdul Kayani¹, Jonathan Mo², Bhaskar Dasgupta¹

Affiliations

¹ From the Rheumatology Department, Mid and South Essex University Hospitals NHS Foundation Trust, Southend University Hospital, Southend-on-Sea, Westcliff-on-Sea, United Kingdom.
² Radiology Department, Mid and South Essex University Hospitals NHS Foundation Trust, Southend University Hospital, Southend-on-Sea, Westcliff-on-Sea, United Kingdom.

PMID: 33616316
DOI: 10.1097/RHU.0000000000001703

No abstract available

MeSH terms

Giant Cell Arteritis* / diagnosis
Giant Cell Arteritis* / drug therapy
Humans
Leflunomide
Takayasu Arteritis*

Substances

Leflunomide